Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Enveric Biosciences Inc (NQ: ENVB ) 0.4710 -0.0080 (-1.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Enveric Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers August 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 07, 2023 Via Benzinga Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More August 03, 2023 A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances... Via Benzinga Cannabis Stock Movers For August 3, 2023 August 03, 2023 Via Benzinga Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial July 28, 2023 UK’s short-acting psychedelics developer Small Pharma (OTCQB: DMTTF) published its financial results for the fiscal first quarter ended May 31, 2023: Via Benzinga Cannabis Stock Gainers And Losers From July 25, 2023 July 25, 2023 Via Benzinga Marijuana Stock Movers For July 31, 2023 July 31, 2023 Via Benzinga Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More July 24, 2023 Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal... Via Benzinga Cannabis Stock Gainers And Losers From July 28, 2023 July 28, 2023 Via Benzinga Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety July 24, 2023 Enveric Biosciences (NASDAQ: ENVB) announced successful completion of preclinical absorption, distribution, metabolism, and excretion (ADME) and toxicology studies conforming to earlier positive... Via Benzinga Cannabis Stock Gainers And Losers From July 26, 2023 July 26, 2023 Via Benzinga Enveric Biosciences Reports Positive Results from Preclinical Studies Supporting Metabolic Profile of Lead Candidate EB-373 July 24, 2023 From Enveric Biosciences Via Business Wire Cannabis Stock Movers For July 24, 2023 July 24, 2023 Via Benzinga Enveric Unveils Positive Results From Animal Studies Of Its Psilocin Prodrug For Anxiety July 17, 2023 Enveric Biosciences (NASDAQ: ENVB) announced positive results from pharmacokinetic animal studies demonstrating oral bioavailability, rapid onset of action and systemic clearance, and a more favorable... Via Benzinga Enveric Biosciences Reports Positive Results from Animal Studies Demonstrating Oral Bioavailability and Well Tolerated Side Effect Profile for EB-373 July 17, 2023 From Enveric Biosciences Via Business Wire Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More July 04, 2023 World's Largest Psychedelics Conference Boasts 12K Attendees Via Benzinga Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety June 26, 2023 Enveric Biosciences (NASDAQ: ENVB) announced the development of an improved formulation of EB-373 designed to enhance the drug product’s scalability, stability, and delivery for ongoing preclinical... Via Benzinga Enveric Biosciences Announces Development of Phase 1-Ready Formulation for EB-373 and Initiation of Scaled Up Manufacturing June 26, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences to Present at H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference June 12, 2023 From Enveric Biosciences Via Business Wire Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023) June 07, 2023 From Enveric Biosciences, Inc. Via Business Wire Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives June 05, 2023 Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent application pertaining to its EVM301 series of... Via Benzinga Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates June 05, 2023 From Enveric Biosciences, Inc. Via Business Wire Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More May 31, 2023 Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 30, 2023 Via Benzinga Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023 May 30, 2023 From Enveric Biosciences, Inc. Via Business Wire Enveric Biosciences Rallies 300% As It Receives US Patents For Psychedelic Compounds May 27, 2023 Enveric Biosciences (ENVB) has recently received two patents for its novel psychedelic compounds, which are modeled from psilocybin mushrooms. Via Talk Markets Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 30, 2023 Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 25, 2023 Via Benzinga Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 25, 2023 Gainers Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 211.6% to $6.86 after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.